Post market approval

What are the problems with market approved products?

Important safety, legal, professional and security requirements must be met when providing medicines storage facilities for market approved products. If medicinal products aren’t stored properly they may not work as promised.

Exposure to light, humidity, and extreme temperatures can break down both prescription and over-the-counter drugs, making them less effective and – in rare cases – even toxic. Likewise, incorrect storage and handling of refrigerated medicines may result in destruction of medicines and financial loss as well as negatively impacting patient safety.

How can we help?

Regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and holding a Wholesale Distribution Authorisation (Human) licence, Cryoniss provides an end-to-end, secure temperature-controlled logistics solution for medicinal products.

Working to Good Distribution Practice, we guarantee the integrity and security of your market approved medicinal products, supporting the storage and distribution of your investigational medicinal products (IMPs) as well as your clinical samples.

All our capabilities are covered by our robust Business Continuity Management System to ensure product integrity is maintained at every stage.

Placing patient safety at the heart of our operations, Cryoniss has implemented a robust Quality Management System (QMS), aligned with our bespoke, world class facilities to ensure the safety and integrity of market approved medicinal products and the wider supply chain.

Product stock management is maintained using a cloud-based inventory management system. Combined with our QMS this ensures that – working alongside our customers and suppliers – we manage the supply chain and provide seamless, hassle-free end-to-end cold chain logistics support.

Want to find out more?

To talk to us about our services and how they can best benefit your business, please get in touch

contact us